211 related articles for article (PubMed ID: 17481662)
21. Surgical incision can alter capsaicin-induced central sensitization in rat brainstem nociceptive neurons.
Lam DK; Sessle BJ; Hu JW
Neuroscience; 2008 Oct; 156(3):737-47. PubMed ID: 18755248
[TBL] [Abstract][Full Text] [Related]
22. Anti-allodynic efficacy of botulinum neurotoxin A in a model of neuropathic pain.
Luvisetto S; Marinelli S; Cobianchi S; Pavone F
Neuroscience; 2007 Mar; 145(1):1-4. PubMed ID: 17218063
[TBL] [Abstract][Full Text] [Related]
23. Neurosensory changes in a human model of endothelin-1 induced pain: a behavioral study.
Hans G; Deseure K; Robert D; De Hert S
Neurosci Lett; 2007 May; 418(2):117-21. PubMed ID: 17403578
[TBL] [Abstract][Full Text] [Related]
24. Effect of local administration of transdermal fentanyl on peripheral opioid analgesia.
Worrich S; Schuler G; Janicki PK
Pain Med; 2007; 8(1):41-7. PubMed ID: 17244103
[TBL] [Abstract][Full Text] [Related]
25. A double-blind, controlled study of botulinum toxin A in chronic myofascial pain.
Qerama E; Fuglsang-Frederiksen A; Kasch H; Bach FW; Jensen TS
Neurology; 2006 Jul; 67(2):241-5. PubMed ID: 16864815
[TBL] [Abstract][Full Text] [Related]
26. A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A.
Voller B; Sycha T; Gustorff B; Schmetterer L; Lehr S; Eichler HG; Auff E; Schnider P
Neurology; 2003 Oct; 61(7):940-4. PubMed ID: 14557564
[TBL] [Abstract][Full Text] [Related]
27. AMPA/kainate antagonist LY293558 reduces capsaicin-evoked hyperalgesia but not pain in normal skin in humans.
Sang CN; Hostetter MP; Gracely RH; Chappell AS; Schoepp DD; Lee G; Whitcup S; Caruso R; Max MB
Anesthesiology; 1998 Nov; 89(5):1060-7. PubMed ID: 9821993
[TBL] [Abstract][Full Text] [Related]
28. The effect of subcutaneous naloxone on experimentally induced pain.
Robertson LJ; Hammond GR; Drummond PD
J Pain; 2008 Jan; 9(1):79-87. PubMed ID: 17964860
[TBL] [Abstract][Full Text] [Related]
29. Botulinum toxin A for treatment of allodynia of complex regional pain syndrome: a pilot study.
Safarpour D; Salardini A; Richardson D; Jabbari B
Pain Med; 2010 Sep; 11(9):1411-4. PubMed ID: 20609130
[TBL] [Abstract][Full Text] [Related]
30. Botulinum toxin for neuropathic pain?
Apfel SC
Neurology; 2009 Apr; 72(17):1456-7. PubMed ID: 19321845
[No Abstract] [Full Text] [Related]
31. The effects of Botulinum Toxin type A on capsaicin-evoked pain, flare, and secondary hyperalgesia in an experimental human model of trigeminal sensitization.
Gazerani P; Staahl C; Drewes AM; Arendt-Nielsen L
Pain; 2006 Jun; 122(3):315-325. PubMed ID: 16677761
[TBL] [Abstract][Full Text] [Related]
32. Botulinum neurotoxin-A for treatment of refractory neck pain: a randomized, double-blind study.
Miller D; Richardson D; Eisa M; Bajwa RJ; Jabbari B
Pain Med; 2009 Sep; 10(6):1012-7. PubMed ID: 19594841
[TBL] [Abstract][Full Text] [Related]
33. Differential effects of peripheral ketamine and lidocaine on skin flux and hyperalgesia induced by intradermal capsaicin in humans.
Gottrup H; Bach FW; Jensen TS
Clin Physiol Funct Imaging; 2004 Mar; 24(2):103-8. PubMed ID: 15056183
[TBL] [Abstract][Full Text] [Related]
34. The effect of systemic lidocaine on pain and secondary hyperalgesia associated with the heat/capsaicin sensitization model in healthy volunteers.
Dirks J; Fabricius P; Petersen KL; Rowbotham MC; Dahl JB
Anesth Analg; 2000 Oct; 91(4):967-72. PubMed ID: 11004058
[TBL] [Abstract][Full Text] [Related]
35. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A.
Aoki KR
Neurotoxicology; 2005 Oct; 26(5):785-93. PubMed ID: 16002144
[TBL] [Abstract][Full Text] [Related]
36. Tonic, phasic, and integrator components of psychophysical responses to topical capsaicin account for differences of location and sex.
Lariviere WR; McBurney DH; Frot M; Balaban CD
J Pain; 2005 Dec; 6(12):777-81. PubMed ID: 16326365
[TBL] [Abstract][Full Text] [Related]
37. Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic hyperalgesia.
Klein T; Magerl W; Hanschmann A; Althaus M; Treede RD
Eur J Pain; 2008 Jan; 12(1):17-29. PubMed ID: 17449306
[TBL] [Abstract][Full Text] [Related]
38. Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis.
Conte A; Bettolo CM; Onesti E; Frasca V; Iacovelli E; Gilio F; Giacomelli E; Gabriele M; Aragona M; Tomassini V; Pantano P; Pozzilli C; Inghilleri M
Eur J Pain; 2009 May; 13(5):472-7. PubMed ID: 18603457
[TBL] [Abstract][Full Text] [Related]
39. Evoked human oesophageal hyperalgesia: a potential tool for analgesic evaluation?
Olesen AE; Staahl C; Brock C; Arendt-Nielsen L; Drewes AM
Basic Clin Pharmacol Toxicol; 2009 Aug; 105(2):126-36. PubMed ID: 19422357
[TBL] [Abstract][Full Text] [Related]
40. Botulinum toxins for analgesia.
Smith HS
Pain Physician; 2009; 12(3):479-81. PubMed ID: 19461815
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
